ACQUISITION (Details Textual) (USD $)	1 Months Ended
	Dec. 29, 2011	Dec. 31, 2012 Series Preferred Stock [Member]	Dec. 29, 2011 Series Preferred Stock [Member]
Business Acquisition Shares Repurchased Percentage	95.00%
Business acquisition shares not surrendered	132,000
Convertible Preferred Stock, Shares Issued upon Conversion	8.89	8.89	8.89
Business Acquisition, Equity Interest Issued Or Issuable, Number Of Shares	281,250
Fair Value Of Shares	$ 2.25
Business Acquisition, Cost of Acquired Entity, Transaction Costs	$ 231,580
Shareholders Description Note Participated In Exchange Transaction	one (1) minority shareholder of TG Bio holding in aggregate 132,000 shares of common stock of TG Bio did not participate
Multiplied by Manhattans fair value of the Common Stock	295,933
Fair value of restricted stock assumed	$ 82,305